Epigenetic Cancer Therapy - Couverture rigide

Couverture rigide

ISBN 10 : 0128002069 ISBN 13 : 9780128002063

Editeur : Academic Press Inc, 2015

Synopsis

Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector.

The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver).

The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.

A propos du livre

À propos de l'auteur

Steven Gray is a Senior Clinical Scientist and Adjunct Assistant Professor in the Thoracic Oncology Research Group, Trinity Centre for Health Sciences at St. James's Hospital, Dublin, Ireland.

Détails de l'édition

• Éditeur: Academic Press Inc
• Date d'édition: 2015
• Langue: anglais
• ISBN 10: 0128002069
• ISBN 13: 9780128002063
• Reliure: Relié
• Nombre de pages: 748
• Éditeur: Gray Steven
• Coordonnées du fabricant: non disponible
• Personne responsable: Yeepin GmbH; 492000000000; sunshine12232@outlook.com; ; Alleestr.11; Kaiserslautern; Rheinland-Pfalz; 67655; Allemagne